2017Äê1ÔÂ23ÈÕÓÉÖпÆÔºÀ¥Ã÷¶¯ÎïËùÀë×ÓͨµÀÒ©ÎïÑз¢ÖÐÐÄ¡¢ÃÀ¹ú¸çÂ×±ÈÑÇ´óѧºÍÇ廪´óѧºÏ×÷Íê³ÉµÄ×îÐÂÑо¿³É¹ûStructural basis of Ca2+/pH dual regulation of the endolysosomal Ca2+ channel TRpML1ÔÚ¡¶×ÔÈ»¡·£¨Nature£©ÔÓÖ¾×Ó¿¯Nature Structural & Molecular BiologyÉÏÔÚÏß·¢±í¡£Ñо¿ÈËÔ±×ÛºÏÔËÓÃXÉäÏß¾§Ìåѧ¡¢ÉúÎﻯѧ¡¢Àä¶³µç×ÓÏÔ΢¾µºÍµçÉúÀíµÈ¼¼ÊõÊֶΣ¬½âÎöÁËIVÐÍÕ³Ö¬ÖÊÖü»ýÖ¢£¨MLIV£©¹Ø¼üµ°°×TRpML1µÄÖØÒª½á¹¹ÓòµÄ¸ß·Ö±æÂÊÈýά½á¹¹£¬½ÒʾÁËÉúÀíÌõ¼þϵÄÀí»¯ÒòËØ£¨¸ÆÀë×ÓºÍËáÐÔpH£©¶ÔTRpML1µÄµ÷¿Ø»úÖÆÒÔ¼°TRpML1¹¦ÄÜʧµ÷ºÍMLIVÏà¹Ø»ùÒòÍ»±äµÄÖ±½ÓÏà¹ØÐÔ¡£

ÈÜøÌåÊÇÒ»ÖÖϸ°ûÆ÷£¬¼´Ï¸°ûÄÚµÄÒ»ÖÖ³¬Î¢½á¹¹£¬Îªµ¥²ã°ü±»µÄÄÒÅÝ£¬¿É½µ½âϸ°ûÄڵĸ÷ÖÖÉúÎï´ó·Ö×Ó£¬²¢ÎªÐµÄÉúÎï´ó·Ö×ÓÌṩԭÁÏ£¬ÊÇϸ°ûµÄ´¦ÀíÓë»ØÊÕϵͳ¡£ÈÜøÌ幦ÄÜȱÏÝÖ±½Óµ¼ÖÂÉúÎï´ó·Ö×Ó²»ÄÜÕý³£½µ½â¶øÔÚÈÜøÌåÖÐÖü»ý£¬Æä½á¹ûÊÇÈÜøÌåËæÖ®·¢ÉúÖ×ÕÍ£¬Ï¸°ûÒ²±äµÃÓ·Ö×ʧ³££¬Ï¸°û¹¦ÄÜÊܵ½ÑÏÖØÓ°Ï죬×îÖÕµ¼Ö¼²²¡£¬³ÆÎªÈÜøÌåÖü»ýÖ¢¡£MLIVΪÈÜøÌåÖü»ýÖ¢µÄÒ»ÖÖ£¬ÆäÖ¢×´±íÏÖΪÖÇÁ¦·¢Óý³Ù»º¡¢ÑÛ¹¦ÄÜÒì³££¨ÈçÊÓÍøÄ¤±äÐÔ£¬½ÇĤ»ì×Ç£©¡¢ÌúºÍθËáȱ·¦¡£»¼ÓÐMLIVµÄ¶ùͯÔÚÒ»Ëêʱ³£±íÏÖ³öÈÏÖª¡¢ÓïÑÔºÍÔ˶¯Õϰ­¡£Ñо¿·¢ÏÖ˲ʱÊÜÌåµçλͨµÀ³ÉÔ±TRpML1ÊÇMLIVµÄÒÅ´«Ö²¡¾ö¶¨ÐÔÒòËØ£¬¶à´ï20ÓàÖÖTRpML1»ùÒòÍ»±ä¿Éµ¼ÖÂMLIV¡£TRpML1Ö÷Òª¶¨Î»ÔÚºóÆÚÄÚº­ÌåºÍÈÜøÌ壬¸ÃͨµÀ¾ßÓÐһЩ·Ç³£ÖØÒªµÄÌØÕ÷£ºÈçÊÜ pH ºÍCa2+ £¨ÈÜøÌåÄÚpHֵԼΪ4.5£¬º¬ 0.5 mM Ca2+£©µ÷½Ú£¬Í¨Í¸Ca2+ ºÍ Fe2+£¨ÈÜøÌ庬¸ßŨ¶ÈµÄ´ËÀà¶þ¼ÛÀë×Ó£©µÈ¡£È»¶ø£¬ÕâÐ©ÌØÕ÷µÄ·Ö×ÓºÍÉúÎïÎïÀí»úÖÆ£¬ÕâЩ»úÖÆÊÇ·ñ¶ÔTRpML1ÔÚÈÜøÌåÖеÄÉúÀí¹¦ÄÜÆðÖÁ¹ØÖØÒªµÄ×÷Óã¬ÒÔ¼°ÈÜøÌåÖü»ýÖ¢Ïà¹Ø»ùÒòÍ»±äËùÔì³ÉµÄTRpML1¹¦ÄÜʧµ÷µÄ·Ö×Ó»úÖÆÄ¿Ç°Éв»Çå³þ¡£

Õë¶ÔÉÏÊöÎÊÌ⣬ÖпÆÔºÀ¥Ã÷¶¯ÎïËùÀë×ÓͨµÀÒ©ÎïÑз¢ÖÐÐÄ¡¢ÃÀ¹ú¸çÂ×±ÈÑÇ´óѧºÍÇ廪´óѧºÏ×÷¶ÔTRpML1ͨµÀ½øÐÐÁËÉîÈëµÄ½á¹¹¹¦ÄÜÑо¿¡£ÎªÁËÁË½â¸ÆÀë×ÓºÍËáÐÔpH¶ÔTRpML1µ÷¿ØµÄ»úÖÆ£¬Ñо¿ÈËÔ±ÖØµãÑо¿Á˸ÃͨµÀµÚI¡¢II¿çĤƬ¶Î£¨TM1 ºÍTM2£©Ö®¼äµÄÒ»¸ö³¤Á¬½ÓƬ¶ÎI-II linker£¬´Ë½á¹¹ÓòÄÚµÄ3ÖÖ°±»ùËáµãÍ»±ä¾ù»áµ¼ÖÂMLIV¡£ËûÃÇ»ñµÃÁËI-II linkerÔÚÈýÖÖ²»Í¬pHֵϵľ§Ìå½á¹¹£¬ÕâÈýÖÖpH¶ÔÓ¦ÓÚÈÜøÌå¡¢ºóÆÚÄÚº­ÌåºÍϸ°û±íÃæÄ¤µÄpHÖµ¡£½á¹¹ÏÔʾI-II linkerΪÐýת¶Ô³ÆµÄËľÛÌ壬ËľÛÌåÖÐÑëÐγÉÒ»¸öÖ±¾¶Îª14 ŵÄÇ»¿×£¨luminal pore£©£¬Í¨¹ýÓÉ16¸ö°±»ùËá²Ð»ù×é³ÉµÄÇ»¿×»·Á¬½Ó¡£¸ÆÀë×ÓºÍÖÊ×Ó×÷ÓÃÓÚ´ËÇ»¿×£¬´Ó¶øË«Öص÷¿ØTRpML1ͨµÀ»îÐÔ£¬·ûºÏÈÜøÌåÄڵĵÍpHÖµºÍ¸ßŨ¶È¸ÆÀë×ÓµÄÀí»¯ÌØÕ÷¡£ËæºóËûÃÇʹÓÃÀä¶³µç¾µ¶ÔÕâÒ»½á¹¹½øÐнøÒ»²½ÑéÖ¤£¬»ñµÃÈ«³¤TRpML1µÄ°ûÍâÓò·Ö±æÂÊΪ5.28ŵĽṹ¡£´Ë°ûÍâÓò¾ø´ó²¿·ÖÓÉI-II linker×é³É£¬ÊÇÒ»¸öËľÛÌ壬ÇÒÖÐÐÄÓÐÒ»¸öºÜ´óµÄ¿×£¬ÕâÒ»½á¹¹ÓëI-II linkerµÄ¾§Ìå½á¹¹¸ß¶ÈÎǺϣ¬±íÃ÷I-II linkerµÄƬ¶Î¾§Ìå½á¹¹µÄÕýÈ·ÐÔ¡£´ËÍ⣬MLIVÖ²¡Í»±ä»á¸Ä±äÕâÒ»½á¹¹ÓòµÄ½á¹¹²¢ÇÒµ¼ÖÂTRpML1ͨµÀµ°°×µÄϸ°ûÄÚÔËÊä·¢Éú´íÎó¡£ÕâÒ»Ñо¿Ê×´ÎΪÁ˽âTRpML1ÕâÒ»ÖØÒªµ°°×µÄµ÷¿Ø£¬×é×°£¬¹¦ÄÜÒÔ¼°MLIVÖ²¡µÄ·Ö×Ó»úÀíÌṩÁ˽ṹ»ù´¡£¬¾ßÓÐÖØÒªµÄ¿ÆÑ§ÒâÒ壬ҲΪMLIVµÄÖÎÁÆÌṩÁËÐÂ˼·¡£


¡¡Í¼a£º¸ÆÀë×ÓºÍpHÖµ¶ÔTRpML1ͨµÀµÄË«ÖØµ÷½Ú¡£Í¼b£º´ÓĤÉÏ·½ËùÊÓµÄTRpML1ͨµÀI-II linkerµÄËľÛÌå½á¹¹¡£Í¼c£º´ÓĤÉÏ·½ËùÊÓµÄI-II linkerµ¥Ìå½á¹¹¡£Í¼d£ºÇ»¿×»·½á¹¹µÄ¾Ö²¿·Å´ó£¬Ö»ÏÔʾÁËÈý¸öÑÇ»ù£¬×îǰ·½µÄÑÇ»ùδÓèÏÔʾÒÔ·½±ã¹Û²ì

À¥Ã÷¶¯ÎïËùÑÑо¿Ô±Îª±¾ÎÄͨѶ×÷Õߣ¬ÃÀ¹ú¸çÂ×±ÈÑÇ´óѧÉúÎï¿ÆÑ§Ïµ¸±Ñо¿Ô±¼°À¥Ã÷¶¯ÎïËù·ÃÎÊѧÕßÀîÃ÷êͲ©Ê¿ºÍÀ¥Ã÷¶¯ÎïËùÕÅ쿸±Ñо¿Ô±Îª±¾ÎĹ²Í¬µÚÒ»×÷Õߣ¬Ç廪´óѧÀîÑ©Ã÷½ÌÊÚΪ±¾ÎĹ²Í¬×÷Õß¡£ÕâÒ»Ñо¿µÃµ½Á˿Ƽ¼²¿973ÏîÄ¿£¬¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÃæÉÏÏîÄ¿£¬ÔÆÄÏÊ¡¿Æ¼¼Ìüº£Íâ¸ß¶ËÈ˲ţ¬ÔÆÄÏÊ¡¸ß²ã´ÎÈ˲ÅÏîÄ¿£¬ÇàÄê****ÒÔ¼°ÃÀ¹ú¹úÁ¢ÎÀÉúÑо¿ÔºµÈ¶àÏî»ù½ðÏîÄ¿µÄÖ§³Ö¡£

×÷Õß¼ò½é£º

Ñ
Ñо¿Ô±
¿Í×ùÑо¿Ô±£¬ÏÖÈÎÀë×ÓͨµÀÒ©ÎïÑз¢ÖÐÐÄÖ÷ÈΣ¬ÃÀ¹ú¸çÂ×±ÈÑÇ´óѧÉúÎï¿ÆÑ§Ïµ½ÌÊÚ¡£×Ô1978ÄêÆðÖÁ½ñ£¬ÏȺóÔÚ±±¾©´óѧ¡¢Öйú¿ÆÑ§ÔºÉϺ£ÄÔÑо¿Ëù¡¢ÃÀ¹úÎ÷ÑÅͼ»ªÊ¢¶Ù´óѧ¡¢Ë¹Ì¹¸£´óѧ¡¢¼ÓÖÝ´óѧ¾É½ðɽ·ÖУµÈ¸ßµÈѧ¸®Ñ§Ï°ÉîÔ죬1997ÄêÈÎÃÀ¹ú¸çÂ×±ÈÑÇ´óѧÉúÎï¿ÆÑ§ÏµÖúÀí½ÌÊÚ£¬2002ÄêÈθ±½ÌÊÚ£¬2009ÄêÈνÌÊÚ¡£µÃµ½ÁËÀ´×ÔSloan, EJLBºÍMcKnight »ù½ð»áµÄѧÕß½±ÒÔ¼°ÃÀ¹úÐÄÔಡѧ»áµÄѧÕ߳ɾͽ±¡£Ôøµ£ÈÎÃÀ¹ú¹úÁ¢ÎÀÉúÑо¿Ôº£¨NIH£©µÄ»ù½ðÆÀίºÍÃÀ¹úÉúÎïÎïÀíÔÓÖ¾(Biophysical Journal) µÄ±àί¡£ÔÚphysiological Reviews¡¢Nature¡¢Nature Neuroscience¡¢Neuron¡¢pNASµÈ¹ú¼ÊÖøÃûѧÊõÆÚ¿¯ÉÏ·¢±íÂÛÎÄ¡£

½ÌÓýºÍ¹¤×÷¾­Àú
1978.9 -1982.7 ±±¾©´óѧ£¬ÉúÎïϵÉúÎïÎïÀíרҵ£¬»ñÀíѧѧʿѧλ
1982.8 -1985.7 Öйú¿ÆÑ§ÔºÉϺ£ÄÔÑо¿Ëù£¬Éñ¾­ÉúÀíרҵ£¬»ñÀíѧ˶ʿѧλ
µ¼Ê¦£ºÉò¿Ë·É½ÌÊÚ
1985.12-1987.8 ÃÀ¹ú¿ÆÂÞÀ­¶àÖÝÁ¢´óѧ£¬½âÆÊÓëÉñ¾­ÉúÎïѧϵ£¬·ÃÎÊѧÕß
µ¼Ê¦£ºStephen D. Roper½ÌÊÚ
1987.9- 1991.6 ÃÀ¹úÎ÷ÑÅͼ»ªÊ¢¶Ù´óѧ£¬ÉúÀí¼°ÉúÎïÎïÀíϵ£¬»ñ²©Ê¿Ñ§Î»
µ¼Ê¦£ºBertil Hille½ÌÊÚ
1991.8-1993.12 ÃÀ¹ú˹̹¸£´óѧ£¬·Ö×ÓÓëϸ°ûÉúÀíѧϵ£¬²©Ê¿ºó
µ¼Ê¦£ºRichard W. Tsien£¨Ç®ÓÀÓÓ£©½ÌÊÚ
1994.1-1996.12 ÃÀ¹ú¼ÓÖÝ´óѧ¾É½ðɽ·ÖУºÍ»ô»ªµÂÐÝ˹ҽѧÑо¿Ôº, ²©Ê¿ºó
µ¼Ê¦£º Lily Y. Jan£¨Ò¶¹«èÌ£©½ÌÊÚ
1997.1- 2002.4 ÃÀ¹ú¸çÂ×±ÈÑÇ´óѧ£¬ÉúÎïѧϵ£¬ÖúÀí½ÌÊÚ
2002.4- 2009.5 ÃÀ¹ú¸çÂ×±ÈÑÇ´óѧ£¬ÉúÎïѧϵ£¬¸±½ÌÊÚ
2009.6- ÖÁ½ñ ÃÀ¹ú¸çÂ×±ÈÑÇ´óѧ£¬ÉúÎïѧϵ£¬½ÌÊÚ
2011.7- ÖÁ½ñ Öйú¿ÆÑ§ÔºÀ¥Ã÷¶¯ÎïËù¿Í×ùÑо¿Ô±

Ñо¿·½Ïò
Éñ¾­ÉúÎïѧºÍÉúÎïÎïÀí£¬Ö÷Òª´ÓʵçѹÃſظÆÍ¨µÀ (VGCC)ºÍ˲ʱ¸ÐÊÜÆ÷µçλ(TRp)ͨµÀµÄ×ÛºÏÑо¿£¬²ÉÓðüÀ¨·Ö×ÓÉúÎïѧ¡¢ÉúÎﻯѧ¡¢Ï¸°ûÉúÎïѧ¡¢Ä¤Æ¬Ç¯¡¢X-ÉäÏß¾§Ìåѧ¡¢¹âѧӰÏñµÈ¶àÖÖÊֶζÔÕâÁ½´óÀàÀë×ÓͨµÀµÄ½á¹¹£¨°üÀ¨Èýά¾§Ìå½á¹¹£©¡¢¹¦Äܺ͵÷¿Ø½øÐÐϵͳµÄÑо¿£¬ÔÚ·Ö×Óˮƽ¡¢Ï¸°ûˮƽ¡¢¶¯Îïˮƽ½âÎöÓÉÓÚÕâЩͨµÀ»ùÒòÍ»±ä»ò¹¦ÄÜʧ³£Ôì³ÉµÄÈËÀ༲²¡£¨Èç°üÀ¨°¢¶û´Äº£Ä¬²¡ÔÚÄÚµÄÉñ¾­ÍËÐÐÐÔ¼²²¡¡¢ñ²ðï¡¢×Ô±ÕÖ¢¡¢ÙªÈåÖ¢¡¢¶àÄÒÉöµÈ£©µÄ·¢²¡»úÀí£¬Ó¦ÓÃÓ«¹â¼ì²âºÍÈ«×Ô¶¯Ä¤Æ¬Ç¯µÈ¸ßͨÁ¿É¸Ñ¡¼¼ÊõÑз¢ÒÔÕâЩͨµÀΪ°ÐµãµÄ»îÐÔ·Ö×ÓºÍÒ©Îï¡£

Ô­ÎÄÕªÒª£º

Structural basis of dual Ca2+/pH regulation of the endolysosomal TRpML1 channel

The activities of organellar ion channels are often regulated by Ca2+ and H+, which are present in high concentrations in many organelles. Here we report a structural element critical for dual Ca2+/pH regulation of TRpML1, a Ca2+-release channel crucial for endolysosomal function. TRpML1 mutations cause mucolipidosis type IV (MLIV), a severe lysosomal storage disorder characterized by neurodegeneration, mental retardation and blindness. We obtained crystal structures of the 213-residue luminal domain of human TRpML1 containing three missense MLIV-causing mutations. This domain forms a tetramer with a highly electronegative central pore formed by a novel luminal pore loop. Cysteine cross-linking and cryo-EM analyses confirmed that this architecture occurs in the full-length channel. Structure¨Cfunction studies demonstrated that Ca2+ and H+ interact with the luminal pore and exert physiologically important regulation. The MLIV-causing mutations disrupt the luminal-domain structure and cause TRpML1 mislocalization. Our study reveals the structural underpinnings of TRpML1"s regulation, assembly and pathogenesis.